-
Two years after Hamas attack, Israelis mourn at Nova massacre site
-
German factory orders drop in new blow to Merz
-
Man City star Stones considered retiring after injury woes
-
Kane could extend Bayern stay as interest in Premier League cools
-
Renewables overtake coal but growth slows: reports
-
OpenAI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Extreme rains hit India's premier Darjeeling tea estates
-
Raducanu retires from opening match in Wuhan heat with dizziness
-
UK's Starmer condemns pro-Palestinian protests on Oct 7 anniversary
-
Tokyo stocks hit new record as markets extend global rally
-
Japan's Takaichi eyes expanding coalition, reports say
-
Canadian PM to visit White House to talk tariffs
-
Indonesia school collapse toll hits 67 as search ends
-
Dodgers hold off Phillies, Brewers on the brink
-
Lawrence sparks Jaguars over Chiefs in NFL thriller
-
EU channels Trump with tariffs to shield steel sector
-
Labuschagne out as Renshaw returns to Australia squad for India ODIs
-
Open AI's Fidji Simo says AI investment frenzy 'new normal,' not bubble
-
Tokyo stocks hit new record as Asian markets extend global rally
-
Computer advances and 'invisibility cloak' vie for physics Nobel
-
Nobel literature buzz tips Swiss postmodernist, Australians for prize
-
Dodgers hold off Phillies to win MLB playoff thriller
-
China exiles in Thailand lose hope, fearing Beijing's long reach
-
Israel marks October 7 anniversary as talks held to end Gaza war
-
Indians lead drop in US university visas
-
Colombia's armed groups 'expanding,' warns watchdog
-
Shhhh! California bans noisy TV commercials
-
Las Vegas, Are You Ready for the Hoedown of the Year?
-
Star Copper Phase 2 Drilling Continues to De-Risk and Expand Footprint to West and North at Star Main System
-
Sales of Licensed Branded Consumer Products Grow 3.4% to Reach $79.3 Billion in Europe, Outpacing Inflation
-
Tocvan Announces Initial Findings From Drone Magnetic Survey At Gran Pilar Gold-Silver Project: Discovery Of Structural Complex In South Block Aligns With Permitted Drill Targets
-
LIRG(TM) Appoints Kurt Dinkelacker as Chief Financial Officer
-
HotelRunner and Visa Partner Globally to Power Embedded and Autonomous Finance in Travel
-
IXOPAY Acquires Congrify, Bringing AI-Powered Insights to Global Payment Orchestration, Tokenization and Compliance
-
Trump 'happy' to work with Democrats on health care, if shutdown ends
-
Trump says may invoke Insurrection Act to deploy more troops in US
-
UNESCO board backs Egyptian for chief after US row
-
Greta Thunberg lands in Greece with expelled Gaza flotilla activists
-
Unreachable Nobel winner hiking 'off the grid'
-
Retirement or marketing gimmick? Cryptic LeBron video sets Internet buzzing
-
CAF 'absolutely confident' AFCON will go ahead in protest-hit Morocco
-
Paris stocks slide amid French political upheaval, Tokyo soars
-
EU should scrap ban on new combustion-engine sales: Merz
-
US government shutdown enters second week, no end in sight
-
World MotoGP champion Marquez to miss two races with fracture
-
Matthieu Blazy reaches for the stars in Chanel debut
-
Macron gives outgoing French PM final chance to salvage government
-
Illinois sues to block National Guard deployment in Chicago
-
Exiled Willis succeeds Dupont as Top 14 player of the season
-
Hamas and Israel open talks in Egypt under Trump's Gaza peace plan
Featured
Last news

New clashes in Serbia as political crisis escalates
Clashes between rival groups of protesters in Serbia flared again late Thursday, police said, as months of anti-government demonstrations boiled over into street violence this week.

Germany sacks rail chief with train network in crisis
The German government sacked the embattled head of Deutsche Bahn on Thursday as it seeks to overhaul the ailing public rail network after years of criticism about deteriorating services.

Greek firefighters beat back wildfires
Greek firefighters gained ground Thursday against a wildfire outside the third-largest city of Patras, while planes bombed water on blazes on three other fronts.

Serbia's political crisis escalates into clashes
Clashes between rival groups of protesters in Serbia left dozens injured overnight, police said Thursday, as months of anti-government demonstrations boiled over into street violence for a second night.

Greek firefighters make progress against wildfires
Firefighters in Greece gained ground Thursday against a wildfire outside the third-largest city of Patras, while water bombers battled blazes on three other fronts.

Inside Trump's 'Alligator Alcatraz': detainees allege abuse in a legal black hole
At US President Donald Trump's new migrant detention center in the Florida Everglades, time has no discernible meaning.

Labor Smart, Inc. - Letter from the CEO Q2 2025 Shareholder Update
Labor Smart, Inc. (OTCID:LTNC) - Letter from the CEO about Q2 2025 Financial Reporting

SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology
Marketing approval allows imminent commercialization of the Colovac device in key EU markets

Applied DNA Reports Third Quarter Fiscal 2025 Financial Results
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended June 30, 2025. The Company's Form 10-Q for its fiscal third quarter can be viewed on the SEC Filings page of its Investor Relations website. The Company will not host a conference call to discuss these results. Applied DNA investor relations remains available for questions at [email protected] .

Wirsh Unveiled Geimori T38: The True Pro-Grade Wireless Electric Portable Coffee Grinder
Innovating on-the-go grinding with uncompromised quality and effortless precision

Laser Photonics (NASDAQ: LASE) Launches One-Year Integrated Media Partnership with New to The Street
Comprehensive campaign features long-form national TV interviews as sponsored programming, monthly earned media, high-frequency commercials, and iconic outdoor advertising

Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
KELOWNA, BC / ACCESS Newswire / August 14, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization ("CRO") has completed the important study milestone known as last patent last visit ("LPLV") in Lexaria's Phase 1b glucagon-like peptide-1 ("GLP-1") study in Australia, GLP-1-H24-4 (the "Study").

Patriot.TV Adds "The David Pollack Show" Expanding it's Weekly Lineup - Riding a Wave of Victories as Viewers Abandon Legacy Media for Streaming and Truth-Based Conservative Reporting
Patriot.TV's Ascent Coincides with a Broader Industry Shift Favoring New Media Over Legacy Networks and Conservative Over Liberal Outlets.

CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
- Live video webcast on Tuesday, August 19th at 2:40 PM ET

Maison Solutions Reports Fiscal Year 2025 Financial Results
MONTEREY PARK, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the fiscal year ended April 30, 2025.

Wellgistics Health Terminates Equity Line of Credit to Further Support Growth Strategy
TAMPA, FLORIDA / ACCESS Newswire / August 14, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the termination of its equity purchase agreement ("ELOC") with Hudson Global Ventures, LLC.

Interactive Strength Inc. (Nasdaq:TRNR) Reports Second Quarter 2025 Results; Increases 2025 Pro Forma Revenue Guidance to More Than $80M
Company Reports Quarterly Revenue of $1.2 Million; Net Loss and Loss per Diluted Share of $2.2 Million and $2.13Quarterly Adjusted EBITDA Loss of $1.7 Million Reflects 40% YOY ImprovementTRNR held 29.6 Million FET tokens as of June 30, 2025 and 67.4 Million FET tokens as of August 13, 2025, with a value in excess of $50 million, representing the largest publicly traded AI-focused Digital Asset TreasuryStockholders' Equity Was $16.3 Million at Quarter End2025 Pro Forma Revenue Guidance Increased to more than $80 Million, driven by Sportstech's Stronger-Than-Expected Performance, and Fourth Quarter Profitability Guidance Reiterated

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg

Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of approximately $2.2 million and increased approximately 10% versus net Q2 2024 revenue of approximately $2.7 millionMytesi prescription volume increased approximately 6.5% in Q2 2025 over Q1 2025 and Mytesi prescription volume in Q2 2025 was equal to the volume in Q2 2024As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in USCompany strategy: Seek business development partnerships for license to develop and commercialize Jaguar's orphan indication products, resulting in non-dilutive funding for JaguarREMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q2 2025 financials and company updates; Click here to register

ANITA & ZAHA Introduces Exclusive "Made in France" Natural Cosmetics
ANITA & ZAHA unveils a premium natural cosmetics range made in France, blending over 93% natural ingredients, luxury design, and eco-conscious values for modern, mindful beauty lovers.

Relief Therapeutics Publishes 2025 Half-Year Report
GENEVAD, SE / ACCESS Newswire / August 14, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced the publication of its 2025 half-year report and provided a corporate update.

Storm makes landfall in China after raking Taiwan as typhoon
Typhoon Podul weakened to a severe tropical storm when it roared ashore in southeastern China early Thursday, state media said, after carving a path across Taiwan, shutting down businesses, grounding flights and knocking out power to thousands of homes.

At least 26 migrants dead in two shipwrecks off Italy
At least 26 migrants died Wednesday when two boats sank off the coast of Italy's Lampedusa island, with around 10 others still missing, the coastguard and UN officials said.

Massive fire burns on mountain near western Canada city
Nearly 20,000 residents of a community in western Canada were on standby Wednesday as a wildfire engulfed a mountain overlooking the city of Port Alberni, the latest area threatened in the country's second-worst fire season on record.

Musk clashes with Altman after accusing App Store of favoring OpenAI
Elon Musk has accused Apple of unfairly favoring ChatGPT on its App Store and threatened legal action, triggering a fiery exchange with OpenAI CEO Sam Altman on Tuesday.

Passwords under threat as tech giants seek tougher security
Fingerprints, access keys and facial recognition are putting a new squeeze on passwords as the traditional computer security method -- but also running into public hesitancy.

Nepra Foods Provides Bi-Weekly MCTO Status Report
VANCOUVER, BC / ACCESS Newswire / August 13, 2025 / Nepra Foods Inc. (CSE:NPRA)(FSE:2P6)(OTCQB:NPRFF) ("Nepra Foods" or the "Company"), announces that further to its news release dated July 30, 2025, the Company voluntarily applied for and the Company's principal regulator, the British Columbia Securities Commission (the "BCSC") granted a management cease trade order (the "MCTO") dated July 30, 2025, under National Policy 12-203 Management Cease Trade Orders ("NP 12-203") and provided the Company with an extension to file its annual financial statements for the period ended March 31, 2025, including the related management's discussion and analysis, and related certifications on or before July 29, 2025 (collectively the "Annual Financial Filings"). The deadline has now been extended to on or before September 29, 2025.

Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
- Dermata announced additional positive data from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial-- Raised $8.8 million in gross proceeds from a private placement and warrant inducement financings during the first half of 2025 -

Onco-Innovations Announces Closing of Private Placement
Not for distribution to United States wire services or for dissemination in the United States

Dolphin Announces Record Q2 Revenue of $14.1 Million, up 23% YoY; Deepens Investment in Women's Sports and Affiliate Marketing
CEO believes Dolphin is undervalued, purchases approximately 1% of outstanding shares since April 2025

Ensysce Biosciences Reports Second Quarter 2025 Financial Results and Latest Program Updates
Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory ApprovalReceives $5.3 Million Installment from NIDA To Support Overdose Protection ProgramAccelerates PF614-MPAR-102 Study with Full Enrollment of Part 2

Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
BOULDER, CO / ACCESS Newswire / August 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced the launch of its HOCl-based diaper rash product for infants and children into large retailers in the United States.